92 related articles for article (PubMed ID: 1830221)
21. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation.
Sell KW; Tadros T; Wang YC; Hertzler G; Knopf WD; Murphy DA; Ahmed-Ansari A
J Heart Transplant; 1988; 7(6):407-18. PubMed ID: 2463352
[TBL] [Abstract][Full Text] [Related]
22. Class II alloantigen induced on corneal endothelium. Role in corneal allograft rejection.
Donnelly JJ; Orlin SE; Wei ZG; Raber IM; Rockey JH
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1315-20. PubMed ID: 2194989
[TBL] [Abstract][Full Text] [Related]
23. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC
J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
[TBL] [Abstract][Full Text] [Related]
25. Changes in the expression of major histocompatibility complex class II antigens in liver allograft rejection.
Hubscher SG; Adams DH; Elias E
J Pathol; 1990 Oct; 162(2):165-71. PubMed ID: 2250195
[TBL] [Abstract][Full Text] [Related]
26. Immunology of corneal allograft rejection: HLA-DR antigens on human corneal cells.
Young E; Stark WJ; Prendergast RA
Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):571-4. PubMed ID: 3884541
[TBL] [Abstract][Full Text] [Related]
27. The modulation of human aortic endothelial cell ICAM-1 (CD-54) expression by serum containing high titers of anti-HLA antibodies.
Hosenpud JD; Shipley GD; Morris TE; Hefeneider SH; Wagner CR
Transplantation; 1993 Feb; 55(2):405-11. PubMed ID: 7679530
[TBL] [Abstract][Full Text] [Related]
28. Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: enhancement by IFN-gamma and TNF-alpha.
Bian H; Reed EF
J Immunol; 1999 Jul; 163(2):1010-8. PubMed ID: 10395699
[TBL] [Abstract][Full Text] [Related]
29. Characterization of in vivo-activated allospecific T lymphocytes propagated from human renal allograft biopsies undergoing rejection.
Mayer TG; Fuller AA; Fuller TC; Lazarovits AI; Boyle LA; Kurnick JT
J Immunol; 1985 Jan; 134(1):258-64. PubMed ID: 3155462
[TBL] [Abstract][Full Text] [Related]
30. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
[TBL] [Abstract][Full Text] [Related]
31. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
[TBL] [Abstract][Full Text] [Related]
32. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of mononuclear cell subsets isolated from the coronary sinus and the right atrium in patients after heart allograft transplantation.
Holzinger C; Zuckermann A; Laczkovics A; Seitelberger R; Laufer G; Andert S; Kink F; Horvart R; Wolner E
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):215-22; discussion 223. PubMed ID: 1865696
[TBL] [Abstract][Full Text] [Related]
35. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft.
van Besouw NM; Daane CR; Vaessen LM; Balk AH; Claas FH; Zondervan PE; Jutte NH; Weimar W
J Heart Lung Transplant; 1995; 14(5):816-23. PubMed ID: 8800715
[TBL] [Abstract][Full Text] [Related]
36. Propagation and characterization of lymphocytes from transplant biopsies.
Duquesnoy RJ; Trager JD; Zeevi A
Crit Rev Immunol; 1991; 10(6):455-80. PubMed ID: 1830745
[TBL] [Abstract][Full Text] [Related]
37. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
[TBL] [Abstract][Full Text] [Related]
38. The role of human endothelial cells in allograft rejection. Some in vitro correlates.
Hirschberg H; Rolstad B; Thorsby E
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):33-6. PubMed ID: 133455
[TBL] [Abstract][Full Text] [Related]
39. Human glomerular smooth muscle (mesangial) cells in culture.
Scheinman JI; Fish AJ; Brown DM; Michael AJ
Lab Invest; 1976 Feb; 34(2):150-8. PubMed ID: 765620
[TBL] [Abstract][Full Text] [Related]
40. Renal allograft rejection: investigation of alloantigen presentation by cultured human renal epithelial cells.
Kirby JA; Ikuta S; Clark K; Proud G; Lennard TW; Taylor RM
Immunology; 1991 Mar; 72(3):411-7. PubMed ID: 1827426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
